Company · CIK 1795579
Calliditas Therapeutics AB
| CIK | 1795579 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | V7 |
| Business address | Sweden |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2021-04-27 |
Offerings
3 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-265881 | 2022-06-28 | 2024-09-16 | 3 | |
| 333-252436 | 2021-01-26 | 2021-02-04 | 2 | |
| 333-238244 | 2020-05-14 | 2020-06-08 | 5 |
Filings
14| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2024-09-16 | EFFECTDeclared effective | 333-265881 | 9999999995-24-002848 |
| 2022-07-08 | EFFECTDeclared effective | 333-265881 | 9999999995-22-002004 |
| 2022-06-28 | F-3Shelf registered | 333-265881 | 0001104659-22-075271 |
| 2021-08-12 | 424B5Shelf takedown | 333-257851 | 0001104659-21-104252 |
| 2021-02-04 | RWWithdrawn | 333-252436 | 0001104659-21-012242 |
| 2021-01-26 | F-1Registration filed | 333-252436 | 0001104659-21-007672 |
| 2020-12-29 | DRSDraft made public | 377-03962 | 0001104659-20-139959 |
| 2020-06-08 | 424B4Final prospectus | 333-238244 | 0001104659-20-070680 |
| 2020-06-04 | EFFECTDeclared effective | 333-238726 | 9999999995-20-001346 |
| 2020-06-04 | EFFECTDeclared effective | 333-238244 | 9999999995-20-001334 |
| 2020-06-04 | F-1/AAmendment | 333-238244 | 0001104659-20-069788 |
| 2020-06-01 | F-1/AAmendment | 333-238244 | 0001104659-20-067977 |
| 2020-05-14 | F-1Registration filed | 333-238244 | 0001104659-20-061227 |
| 2019-12-13 | DRSDraft made public | 377-02953 | 0001104659-19-072662 |